Identification of antipsychotic drug fluspirilene as a potential p53-MDM2 inhibitor: a combined computational and experimental study.
about
In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer DrugMedicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction.Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine
P2860
Identification of antipsychotic drug fluspirilene as a potential p53-MDM2 inhibitor: a combined computational and experimental study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Identification of antipsychoti ...... tional and experimental study.
@en
type
label
Identification of antipsychoti ...... tional and experimental study.
@en
prefLabel
Identification of antipsychoti ...... tional and experimental study.
@en
P2093
P2860
P1476
Identification of antipsychoti ...... tional and experimental study.
@en
P2093
John C Ruggiero
John W Stoddart
Jonathan D Griffin
Joseph J Butera
Joseph M Notarfrancesco
Kevin S Gilroy
Michael F Pacitti
Sachin P Patil
Shawn Tran
P2860
P2888
P304
P356
10.1007/S10822-014-9811-6
P577
2014-11-07T00:00:00Z